H. Curé

2.9k total citations
82 papers, 2.0k citations indexed

About

H. Curé is a scholar working on Oncology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, H. Curé has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 18 papers in Cancer Research and 17 papers in Reproductive Medicine. Recurrent topics in H. Curé's work include Cancer Treatment and Pharmacology (23 papers), Ovarian cancer diagnosis and treatment (16 papers) and Breast Cancer Treatment Studies (16 papers). H. Curé is often cited by papers focused on Cancer Treatment and Pharmacology (23 papers), Ovarian cancer diagnosis and treatment (16 papers) and Breast Cancer Treatment Studies (16 papers). H. Curé collaborates with scholars based in France, United States and Netherlands. H. Curé's co-authors include P. Chollet, J Dauplat, G. Le Bouëdec, Frédérique Penault‐Llorca, S. Amat, M de Latour, M-A Mouret-Reynier, Achard Jl, V. Feillel and Fabrice Kwiatkowski and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

H. Curé

79 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Curé France 22 1.2k 742 410 367 327 82 2.0k
D. Fennelly Ireland 25 1.8k 1.4× 377 0.5× 332 0.8× 878 2.4× 564 1.7× 85 2.6k
H. Hausmaninger Austria 21 1.3k 1.1× 910 1.2× 287 0.7× 206 0.6× 248 0.8× 53 2.2k
Daniel Vorobiof South Africa 18 938 0.8× 300 0.4× 340 0.8× 156 0.4× 390 1.2× 61 1.6k
J. L. Misset France 27 2.1k 1.8× 566 0.8× 438 1.1× 452 1.2× 1.0k 3.2× 63 3.0k
Kurt Brunner Switzerland 23 818 0.7× 274 0.4× 250 0.6× 504 1.4× 452 1.4× 82 1.7k
Mayu Yunokawa Japan 25 1.1k 0.9× 373 0.5× 157 0.4× 194 0.5× 482 1.5× 140 2.1k
Rita Lionetto Italy 20 962 0.8× 295 0.4× 228 0.6× 295 0.8× 320 1.0× 53 1.4k
Stephen Shibata United States 28 1.2k 1.0× 226 0.3× 189 0.5× 545 1.5× 601 1.8× 84 2.2k
Edward Wight Switzerland 22 684 0.6× 745 1.0× 398 1.0× 350 1.0× 189 0.6× 60 1.6k
D. Amoroso Italy 23 2.0k 1.6× 925 1.2× 308 0.8× 270 0.7× 791 2.4× 104 2.8k

Countries citing papers authored by H. Curé

Since Specialization
Citations

This map shows the geographic impact of H. Curé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Curé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Curé more than expected).

Fields of papers citing papers by H. Curé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Curé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Curé. The network helps show where H. Curé may publish in the future.

Co-authorship network of co-authors of H. Curé

This figure shows the co-authorship network connecting the top 25 collaborators of H. Curé. A scholar is included among the top collaborators of H. Curé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Curé. H. Curé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sussman, Jonathan, H. Curé, Salina Yuan, et al.. (2025). In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity. Genes & Development. 39(9-10). 603–616. 2 indexed citations
2.
Katsuda, Takeshi, Jonathan Sussman, Kenji Ito, et al.. (2024). Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity. Nature Communications. 15(1). 1761–1761. 13 indexed citations
3.
Katsuda, Takeshi, H. Curé, Jonathan Sussman, et al.. (2022). Rapid in vivo multiplexed editing (RIME) of the adult mouse liver. Hepatology. 78(2). 486–502. 7 indexed citations
4.
Baños, Fabián Juliao, Claudia Jaramillo, Luis Sabbagh, et al.. (2021). Clinical utility of the small bowel capsule endoscopy in the study of small bowel diseases in Colombia: Results of a national registry. Gastroenterología y Hepatología (English Edition). 44(5). 346–354. 1 indexed citations
5.
Papathanassiou, Dimitri, Jean-Christophe Eymard, Aude-Marie Savoye, et al.. (2013). Comparaison des performances diagnostiques de la TEP au FNa avec et sans scanner couplé dans la recherche de métastases osseuses. Médecine Nucléaire. 37(2). 19–25.
6.
Gonçalvès, Anthony, Étienne Brain, Carole Tarpin, et al.. (2012). Abstract OT2-3-05: AVASTEM: a phase II randomized trial evaluating anti-cancer stem cell activity of pre-operative bevacizumab and chemotherapy in breast cancer. Cancer Research. 72(24_Supplement). OT2–3. 3 indexed citations
7.
Curé, H., et al.. (2010). Criterios para la producción de Phytoseiulus persimilis (Parasitiformes: Phytoseiidae) bajo condiciones de invernadero. 15(1). 37–46. 3 indexed citations
8.
9.
Abrial, Catherine, Marianne Leheurteur, Aurélie Cabrespine, et al.. (2005). Aromatase inhibitors and metastatic breast cancer survival. Journal of Clinical Oncology. 23(16_suppl). 767–767. 1 indexed citations
10.
Fumoleau, P., R. Largillier, Véronique Dièras, et al.. (2003). Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. European Journal of Cancer. 40(4). 536–542. 247 indexed citations
11.
Pigneux, Arnaud, M-L. Tanguy, Mauricette Michallet, et al.. (2002). Prior treatment with alpha interferon does not adversely 
affect the outcome of allogeneic transplantation 
for chronic myeloid leukaemia. British Journal of Haematology. 116(1). 193–201. 15 indexed citations
12.
Chollet, P., S. Amat, H. Curé, et al.. (2002). Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. British Journal of Cancer. 86(7). 1041–1046. 207 indexed citations
13.
Charrier, Sabine, P. Chollet, J.-O. Bay, et al.. (2000). Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer. Bone Marrow Transplantation. 25(7). 705–710. 2 indexed citations
14.
Kwiatkowski, Fabrice, et al.. (1999). Chrono-pharmacocinétique du 5-fluoro-uracile dans le traitement des cancers colorectaux métastatiques et indicateurs de réponse métabolique. Journal de Pharmacie Clinique. 18(2). 138–143. 1 indexed citations
15.
16.
Bay, J.-O., Marc Fouassier, David M. Beal, et al.. (1997). Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphotic leukemia. PubMed. 39(4). 209–212. 11 indexed citations
17.
Chollet, P., M.A. Bensmaïne, S. Brienza, et al.. (1996). Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer. Annals of Oncology. 7(10). 1065–1070. 124 indexed citations
18.
Curé, H., Michel Legros, J Fleury, et al.. (1996). High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer.. PubMed. 18 Suppl 1. S34–5. 1 indexed citations
19.
Droz, J.P., Pierre Biron, Pierre Kerbrat, et al.. (1993). Early Intensified Chemotherapywith AutologousBone Marrow Transplantation inFirst Line Treatment ofPoor Risk Non-SeminomatousGerm Cell Tumours. European Urology. 23(1). 213–218. 69 indexed citations
20.
Thévenet, Julien, et al.. (1987). [Pancytopenia during treatment of rheumatoid arthritis with methotrexate after administration of trimethoprim-sulfamethoxazole].. PubMed. 16(30). 1487–1487. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Fennelly Breakdown of academic impact, for papers by H. Hausmaninger Breakdown of academic impact, for papers by Daniel Vorobiof Breakdown of academic impact, for papers by J. L. Misset Breakdown of academic impact, for papers by Kurt Brunner Breakdown of academic impact, for papers by Mayu Yunokawa Breakdown of academic impact, for papers by Rita Lionetto Breakdown of academic impact, for papers by Stephen Shibata Breakdown of academic impact, for papers by Edward Wight Breakdown of academic impact, for papers by D. Amoroso
Rankless by CCL
2026